Ascend Laboratories Recalls 10mg Amlodipine Tablets Due to Foreign Tablets
Ascend Laboratories recalls 10mg Amlodipine Besylate tablets (NDC 67877-199-10) with foreign 2.5mg tablets. This may cause incorrect dosing if taken without knowing the tablet size.
Lower-risk recall
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
Contact the company
What happened, in plain English
Ascend Laboratories is recalling 10mg Amlodipine Besylate tablets that contain foreign 2.5mg tablets. This could lead to incorrect dosing if someone takes the tablets without checking the size. Read more at govinfonow.com/recall/41632-ascend-laboratories-recalls-10mg-amlodipine-tablets-due-to-foreign-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/41632-ascend-laboratories-recalls-10mg-amlodipine-tablets-due-to-foreign-tablets · Updated October 8, 2026 · FDA enforcement record: FDA #D-1134-2017
Cite this page
“Ascend Laboratories Recalls 10mg Amlodipine Tablets Due to Foreign Tablets.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41632-ascend-laboratories-recalls-10mg-amlodipine-tablets-due-to-foreign-tablets. Based on FDA recall #D-1134-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1134-2017%22&limit=1).
Why it’s dangerous
The bottles contain both 10mg and 2.5mg Amlodipine Besylate tablets. If someone takes a 2.5mg tablet instead of a 10mg tablet, they may get an incorrect dose of medication.
Who’s affected
People who have the 1000-count bottle of 10mg Amlodipine Besylate tablets (NDC 67877-199-10) from Ascend Laboratories. Those taking the medication for high blood pressure are most at risk.
How to tell if you have this one
Check for the 1000-count bottle labeled 'Amlodipine Besylate 10 mg' with NDC 67877-199-10. The lot number is 6142626, expiring September 2019.
- Brand
Ascend Laboratories- Category
Drug
What to do — step by step
Check Tablet Size
Look for 2.5mg tablets in the bottle; if found, do not take them.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Ascend Laboratories recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1134-2017 (May 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1134-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.